SCHEMBL27436767

SCHEMBL27436767

O=C(CCl)N1CCc2ccc(Br)cc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XIAP P98170 2/20 0.56
BIRC2 Q13490 2/20 0.56
CASP2 P42575 2/20 0.52
MAPT P10636 3/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
POLB P06746 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
NFKB1 P19838 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
HTR2B P41595 1/20 0.47
HIF1A Q16665 1/20 0.47
NOTUM Q6P988 2/20 0.47
TSHR P16473 1/20 0.46
DRD2 P14416 3/20 0.46
DRD4 P21917 3/20 0.46
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18763042 0.88 SLC22A12 (0.58) XIAPBIRC2CASP2MAPTNPC1
SCHEMBL11224906 0.83 NOTUM (0.68) XIAPBIRC2CASP2MAPTHTR2A
SCHEMBL17494980 0.81 XIAP (0.51) XIAPBIRC2MAPTNPC1RAB9A
SCHEMBL4543419 0.80 NOTUM (0.67) XIAPBIRC2CYP1A2CYP3A4CYP2D6
SCHEMBL2675861 0.79 PDK1 (0.56) CASP2MAPTNPC1LMNASLC22A12
SCHEMBL30911998 0.79 NOTUM (0.53) XIAPBIRC2MAPTNPC1RAB9A
SCHEMBL20612406 0.79 XIAP (0.66) XIAPBIRC2MAPTDRD2DRD4
SCHEMBL30912021 0.79 MAPT (0.52) XIAPBIRC2MAPTNPC1RAB9A
SCHEMBL8893534 0.78 XIAP (0.58) XIAPBIRC2CASP2MAPTNPC1
SCHEMBL27165463 0.78 BIRC2 (0.60) XIAPBIRC2CASP2MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024133499-A1 GLYCINE DERIVATIVES WITH P2X4 RECEPTOR-BLOCKING ACTIVITY AS DIAGNOSTICS AND FOR THE TREATMENT OF PAIN, INFLAMMATION, CANCER, AND OTHER P2X4 RECEPTOR-RELATED DISEASES RHEINISCHE-FRIEDRICH-WILHELMS-UNIVERSITÄT BONN (DE) 2024-06-27 WO disclosed